Dr. Ola Landgren shares a clinical trial about smoldering myeloma. Join the REVIVE trial study for highrisk smoldering myeloma study here.  (https://healthtree.org/myeloma/commun...)



He also share about his research partnership with HealthTree on a personalized medicine study (https://healthtree.org/myeloma/curehu...)  that creates a computerized model of risk prediction and treatment recommendations for newly diagnosed patients. 



This is a study that is open to all myeloma patients regardless of where they are being treated. The only involvement by patients is to sign a consent form and connect their medical records which requires less than 5 minutes of participation.